Company profile: Unilabs
1.1 - Company Overview
Company description
- Provider of outsourced diagnostic services, including clinical laboratory testing and medical diagnostic imaging. Operates over 112 laboratories and 43 imaging units with a catalogue of more than 2,500 diagnostic tests. Headquartered in Geneva, the company is one of Europe's leading providers and serves private and public healthcare providers.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Unilabs
DermTech
HQ: United States
Website
- Description: Provider of non-invasive qPCR assays for skin samples collected via adhesive tape biopsy, analyzing multiple gene targets' RNA expression. Offerings include the DermTech Melanoma Test, a genomic test using adhesive tape-collected skin cells to detect markers associated with melanoma with a 99% negative predictive value, anticipated to be provided through a CLIA-certified laboratory in San Diego.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DermTech company profile →
Focus Diagnostics
HQ: United States
Website
- Description: Provider of molecular and immunodiagnostic products and platforms for hospitals and commercial laboratories worldwide. Offers Simplexa molecular chemistries, HerpeSelect type-specific serology, and DxSelect IFA/ELISA kits for diseases such as West Nile Virus and Rickettsia, plus Luminex LTG, LIAISON PLEX multiplexing (including Respiratory Flex Assay), and LIAISON XL/XS automated CLIA assays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Focus Diagnostics company profile →
Blueprint Genetics
HQ: Finland
Website
- Description: Provider of clinical genetic testing and diagnostics for rare diseases using NGS, serving hospitals and research groups. Offerings include Whole Exome Sequencing, panel-based NGS, variant interpretation with clinical statements per ACMG guidelines, and a Quality Management System with analytic validation and quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Blueprint Genetics company profile →
AlliedPath
HQ: United States
Website
- Description: Provider of cancer-focused molecular diagnostics testing, offering an extensive menu of high-quality, solid tumor specific molecular tests to regional hospital and reference laboratories, with test results combined with expert pathology analysis into an easy-to-interpret patient report.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AlliedPath company profile →
Isarna Therapeutics
HQ: Germany
Website
- Description: Provider of selective TGF-β inhibitors and antisense oligonucleotide therapies, advancing a pipeline of novel oligonucleotides and combination modalities. Offerings include ISTH0036, an antisense oligonucleotide in Phase 2a for ophthalmic conditions, and therapies targeting TGF-β signaling for fibrotic liver disease, NASH, and various cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Isarna Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Unilabs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Unilabs
2.2 - Growth funds investing in similar companies to Unilabs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Unilabs
4.2 - Public trading comparable groups for Unilabs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →